Insightec vs Moderna
Side-by-side comparison of AI visibility scores, market position, and capabilities
Insightec is an Israeli medtech company founded in 1999 with $574M+ raised; its Exablate Neuro platform received FDA approval for bilateral Parkinson's disease treatment in July 2025;
About
Insightec is a privately held medical device company founded in 1999 and headquartered in Tirat Carmel, Israel, with offices in Dallas, Miami, Shanghai, and Tokyo. The company pioneered MR-guided focused ultrasound (MRgFUS) technology — a non-invasive surgical modality that uses focused acoustic energy guided in real time by magnetic resonance imaging to precisely destroy deep tissue targets within the body without incisions, radiation, or anesthesia. The technology achieves sub-millimeter precision while MRI provides continuous temperature monitoring to ensure safety and efficacy throughout each treatment.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
About
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.